LSL Pharma Group Inc. (TSXV:LSL)

LSL Pharma Group Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4.97	0.3	0.01	-	0.74	1.93
Cash & Short-Term Investments	4.97	0.3	0.01	-	0.74	1.93
Cash Growth	1619.38%	3600.00%	-	-	-61.52%	316.66%
Accounts Receivable	5.2	4.8	2.55	0.97	1.12	2.22
Other Receivables	0.01	0.15	0.13	0.07	0.22	0.19
Receivables	5.21	4.96	2.68	1.04	1.33	2.4
Inventory	12.38	9.12	4.11	2.96	4.17	2.13
Prepaid Expenses	0.66	1.01	0.41	0.21	0.13	0.05
Other Current Assets	-	-	-	0.19	0.11	-
Total Current Assets	23.22	15.38	7.2	4.4	6.48	6.51
Property, Plant & Equipment	24.37	22.94	14.75	13.92	12.89	10.3
Goodwill	0.16	0.16	-	-	-	-
Other Intangible Assets	13.77	13.27	8.93	8.98	9.39	9.81
Long-Term Deferred Tax Assets	0.22	0.22	-	-	-	0.1
Other Long-Term Assets	0.06	1.54	0.02	0.02	0.28	0.46
Total Assets	61.8	53.51	30.9	27.31	29.03	27.18
Accounts Payable	7.52	4.5	4.92	4.54	2.54	2.47
Accrued Expenses	-	0.69	1.06	1.58	1.17	1.64
Short-Term Debt	8.99	2.56	3.77	2.91	-	-
Current Portion of Long-Term Debt	1.17	1.45	5.22	1.58	1.89	6.03
Current Portion of Leases	0.47	0.45	0.12	0.14	0.19	0.24
Current Unearned Revenue	-	-	-	0.01	-	0.51
Other Current Liabilities	-	-	-	0.87	1.46	1.66
Total Current Liabilities	18.15	9.65	15.07	11.62	7.25	12.55
Long-Term Debt	13.29	12.75	4.73	7.84	7.98	3.36
Long-Term Leases	4.18	4.43	2.44	2.56	2.69	0.94
Long-Term Deferred Tax Liabilities	1.79	1.79	-	-	-	-
Total Liabilities	37.4	28.62	22.25	22.02	17.92	16.84
Common Stock	36.39	36.39	24.2	15.05	12.81	10.26
Additional Paid-In Capital	3.1	3.05	2.32	-	-	-
Retained Earnings	-15.46	-14.92	-18.23	-9.76	-1.7	0.08
Comprehensive Income & Other	0.38	0.38	0.38	-	-	-
Shareholders' Equity	24.4	24.89	8.66	5.29	11.11	10.34
Total Liabilities & Equity	61.8	53.51	30.9	27.31	29.03	27.18
Total Debt	28.1	21.64	16.27	15.03	12.74	10.57
Net Cash (Debt)	-23.13	-21.34	-16.26	-15.03	-12	-8.64
Net Cash Per Share	-0.20	-0.20	-0.20	-0.23	-0.20	-0.16
Filing Date Shares Outstanding	115.53	115.53	82.44	68.09	62.66	54.89
Total Common Shares Outstanding	115.53	115.53	82.44	68.09	62.66	54.89
Working Capital	5.07	5.72	-7.87	-7.22	-0.78	-6.04
Book Value Per Share	0.21	0.22	0.10	0.08	0.18	0.19
Tangible Book Value	10.47	11.46	-0.28	-3.69	1.72	0.54
Tangible Book Value Per Share	0.09	0.10	-0.00	-0.05	0.03	0.01
Land	-	0.56	0.28	0.28	0.28	0.28
Buildings	-	5.61	3.97	3.91	3.63	3.51
Machinery	-	11.41	6.02	5.55	5.33	4.73
Construction In Progress	-	-	-	1.77	0.47	-
Leasehold Improvements	-	3.99	3.71	0.93	0.93	0.82

Source: S&P Global Market Intelligence. Standard template. Financial Sources.